Author

H. Weighardt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Huang· 1 shared A. Pfeifer· 1 shared B. Niemann· 1 shared C. Alter· 1 shared C. Esser· 1 shared C. Kirschning· 1 shared C. Thiele· 1 shared F. Gondorf· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Huang

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differential cell type-specific function of the aryl hydrocarbon receptor and its repressor in diet-induced obesity and fibrosis

F. J. Graelmann, F. Gondorf, Y. Majlesain, B. Niemann, K. Klepac, M. Gottschalk, M. Mayer, I. Iriady, P. Hatzfeld, S. K. Lindenberg, K. Wunderling, C. Thiele, Z. Abdullah, W. He, K. Hiller, , L. Reverte-Salisa

This study investigates the cell type-specific roles of AhR and AhRR in diet-induced obesity and fibrosis, finding that AhRR deficiency protects from metabolic dysfunction and liver damage, while AhR deficiency worsens outcomes.

Molecular Metabolism · Jul 1, 2024Peer-reviewedImmunology

The mycotoxin Beauvericin exhibits immunostimulatory effects on dendritic cells via activating the TLR4 signaling pathway

X. Yang, S. Ali, M. Zhao, L. Richter, V. Schafer, J. S. Diecks, M. Frank, J. Qi, P. K. Larsen, J. Skerra, H. Islam, T. Wachtmeister, C. Alter, A. Huang, S. Bhatia, , S. Scheu

This study identifies Beauvericin as an activator of dendritic cells via the TLR4 signaling pathway, suggesting its potential as a vaccine adjuvant or cancer immunotherapy.

bioRxiv · Jan 20, 2022Immunology